Overexpression of p16INK4A in liquid-based specimens (SurePath™) as marker of cervical dysplasia and neoplasia

Diagnostic Cytopathology

Volumn 27, Issue 6, 2002, Pages 365-370

  Saqi, Anjali ^a   Pasha, Theresa L ^a   McGrath, Cindy M ^a   Yu, Gordon H ^a   Zhang, Paul ^a   Gupta, Prabodh ^a,b  

^a University of PA Health System   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Human papillomavirus (HPV); Liquid based cytology Pap smears; p16INK4A; SurePath

Indexed keywords

ANTIBODY; PROTEIN P16; PROTEIN P16INK4A; TUMOR MARKER;

ADENOCARCINOMA; ADULT; AGED; ANTIGEN ANTIBODY REACTION; ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; CYTOPLASM; DISEASE MARKER; FEMALE; GYNECOLOGIC DISEASE; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TISSUE PREPARATION; UTERINE CERVIX DYSPLASIA; UTERINE CERVIX TUMOR; WART VIRUS; CARCINOMA; CHEMISTRY; DIAGNOSTIC ERROR; IMMUNOHISTOCHEMISTRY; METABOLISM; METHODOLOGY; MIDDLE AGED; PATHOLOGY; VAGINA SMEAR; VALIDATION STUDY;

ADULT; AGED; CARCINOMA; CELL NUCLEUS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DIAGNOSTIC ERRORS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL DYSPLASIA; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 0036895918     PISSN: 87551039     EISSN: None     Source Type: Journal    
DOI: 10.1002/dc.10205     Document Type: Article

References (17)

1. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics. CA Cancer J Clin 1998;48:6-29.
2. National Cancer Institute. Surveillance Epidemiology and End-Results. Washington, DC: Dept. of Health and Human Services; 2000.
3. Solomon D, Davey D, Kurman R, et al. The 2001 Bethesda System terminology for reporting results of cervical cytology. JAMA 2002;287:2114-2119.
4. Stoler MH, Schiffman M. Interobserver reproducibility of cervical cytologic and histologic interpretations: Realistic estimates from the ASCUS-LSIL Triage study. JAMA 2001;285:1500-1505.
5. McCluggage WG, Walsh MY, Thornton CM, et al. Inter- and intra-observer variation in the histopathologic reporting of cervical squamous intraepithelial lesions using a modified Bethesda grading system. Br J Obstet Gynaecol 1998;105:206-210.
6. Klaes R, Woerner SM, Ridder R, et al. Detection of high-risk cervical intraepithelial neoplasia and cervical cancer by amplification of transcripts derived from integrated papillomavirus oncogenes. Cancer Res. 1999;59:6132-6136.
7. Anton M, Horky M, Blaha O. The role of tumour suppressors and viral oncoproteins in cervical carcinogenesis. Ceska Gynekol 2000;65:275-278.
8. Cotran R, Kumar V, Collins T. Pathologic Basis of Disease. Philadelphia: W.B. Saunders; 1998. p 272-293.
9. Klaes R, Friedrich T, Spitkovsky D, et al. Over expression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 2001;92:276-284.
10. Keating JT, Cyiko A, Riethdorf S, et al. Ki-67, cyclin E, and p16INK4 are complimentary surrogate biomarkers for human papilloma virus-related cervical neoplasia. Am J Surg Pathol 2001;25:884-891.
11. Hirama T, Miller CW, Wilczynski SP, Koeffler HP. p16 (CDKN2/cyclin-dependent kinase-4 inhibitor/multiple tumor suppressor-1) gene is not altered in uterine cervical carcinomas or cell lines. Mod Pathol 1996;9:26-31.
12. Sano T, Oyama T, Kashiwabara K, Fukuda T, Nakajima T. Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions. Am J Pathol. 1998;153:1741-1748.
13. Sano T, Oyama T, Kashiwabara K, Fukuda T, Nakajima T. Immunohistochemical over expression of p16 protein associated with intact retinoblastoma protein expression in cervical cancer and cervical intraepithelial neoplasia. Pathol Int 1998;48:580-585.
14. Bibbo M, Klump WJ, DeCecco J, Kovatich AJ. Procedure for immunocytochemical detection of P16INK4A antigen in thin-layer, liquid-based specimens. Acta Cytol 2002;46:25-29.
15. Kim JW, Namkoong SE, Ryu SW, et al. Absence of p15INK4B and p16INK4A gene alterations in primary cervical carcinoma tissues and cell lines with human papillomavirus infection. Gynecol Oncol 1998;70:75-79.
16. Kuhn L, Denny L, Pollack A, Lorincz A, Richart RM, Wright TC. Human papillomavirus DNA testing for cervical cancer screening in low-resource settings. J Natl Cancer Inst 2000;92:818-825.
17. Bovicelli A, Bristow RE, Moritz FJ. HPV testing: Where are we now? Anticancer Res 2000;20:4673-4680.